The Endocrine Society now issued a Clinical Practice Guideline (CPG) advising against the usage of testosterone therapy in healthy women. Although the FDA approved testosterone therapy for the treatment of diseases affecting the testes, pituitary and hypothalamus, it has not been approved for treating age-related declines in testosterone levels. The U.S. National Institute on Aging is also anticipated to release the results of research on the safety of testosterone. The study involved about 800 older men with low testosterone and symptoms associated with this ailment, such http://tinyurl.com/jkhvqy9 as sexual and physical dysfunction. Since the men's heart health was monitored, the research is expected to shed more light on the safety of testosterone treatment.
The recent conflicting findings on testosterone therapy prompted Patel and his team to conduct a big systematic literature search for studies assessing the relationship between testosterone replacement therapy and cardiovascular events among guys. An estimated 13 million men in the USA suffer with low testosterone, which occurs when the body does not make enough hormones because of a problem with the testicles or pituitary gland. This describes an individual's sudden weight gain, obvious aging and decline of energy.
And many girls have a knee-jerk suspicion that any hormone treatment can raise their risk of breast cancer. Nevertheless, clinical studies demonstrate that testosterone not only doesn't increase a woman's risk of breast cancer , it may play a vital role in warding off the disease. Glaser believes this will likely remain the status quo for a while, given the prohibitive cost of running the long-term safety studies needed to win fuller FDA acceptance.
Адрес сайта: http://tinyurl.com/jkhvqy9